Cargando…
Association of RDM1 with osteosarcoma progression via cell cycle and MEK/ERK signalling pathway regulation
RAD52 motif‐containing 1 (RDM1), a key regulator of DNA double‐strand break repair and recombination, has been reported to play an important role in the development of various human cancers, such as papillary thyroid carcinoma, neuroblastoma and lung cancer. However, the effect of RDM1 on osteosarco...
Autores principales: | Sheng, Jun, Liu, Kun, Sun, Dawei, Nie, Piming, Mu, Zhiping, Chen, Hui, Zhang, Zhengfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8358872/ https://www.ncbi.nlm.nih.gov/pubmed/34264012 http://dx.doi.org/10.1111/jcmm.16735 |
Ejemplares similares
-
RDM1 promotes neuroblastoma growth through the RAS–Raf–MEK–ERK pathway
por: Xie, Guojin, et al.
Publicado: (2019) -
Loss of RDM1 enhances hepatocellular carcinoma progression via p53 and Ras/Raf/ERK pathways
por: Chen, Shi‐Lu, et al.
Publicado: (2019) -
Hematopoietic cell kinase enhances osteosarcoma development via the MEK/ERK pathway
por: Liu, Weibo, et al.
Publicado: (2021) -
Caltech RDM by TIND
por: Bjorkoy, Audun
Publicado: (2017) -
Down-regulation of TRIB3 inhibits the progression of ovarian cancer via MEK/ERK signaling pathway
por: Wang, Shuang, et al.
Publicado: (2020)